CSF3 and acute myeloid leukemia: In acute myeloid leukemia (AML) mouse models, quiescent chemotherapy-resistant AML stem cells can be induced to enter the cell cycle by treatment with granulocyte colony-stimulating factor (G-CSF), which then increases sensitivity for the chemotherapeutic Cytarabine (AraC) [228].